Ken Griffin Lucira Health, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lucira Health, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 21,200 shares of LHDX stock, worth $636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,200Holding current value
$636% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LHDX
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About Lucira Health, Inc.
- Ticker LHDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,106,500
- Market Cap $1.2M
- Description
- Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...